Reshape Biotech Analysis: $8M Raised

• Start-up: $2,417 per month, paid annually
  • 1 incubated Imaging Device
  • Out-of-the-box AI models
  • Single lab platform access
  • Smooth onboarding to get you started
• Standard: $11,999 per month, paid annually
  • 5 incubated Imaging Devices
  • Out-of-the-box AI models
  • Single lab platform access
  • 1-2 custom AI models
  • API access for seamless integrations
  • Dedicated onboarding and support
• Enterprise: Custom pricing
  • Flexible device configurations
  • Out-of-the-box AI models
  • Multi-lab platform access
  • White-glove onboarding
  • Custom AI models
  • API access for seamless integrations
  • Priority customer support

Reshape Biotech operates in the biotechnology sector, focusing on automating laboratory experiments and utilizing machine learning for data analysis. Its main competitors include:

1. Nagi Bioscience: Develops laboratory equipment aimed at reducing animal testing through automated systems for screening small organisms. Their focus on toxicology safety assessments provides a unique advantage in the pharmaceutical and agricultural sectors.

2. Ogi Bio: Specializes in automation solutions for microbial culturing, offering modular devices that enhance efficiency in laboratory settings. Their emphasis on streamlining microbial research distinguishes them in the biotechnology market.

3. Biodock: Utilizes deep AI for biological image analysis, simplifying the interpretation of biological data. This AI-driven approach sets them apart in the field of data analysis within biotechnology.

4. Nordic BioSite: Provides a broader range of research and diagnostic solutions, which may offer more comprehensive product offerings compared to Reshape Biotech's specific focus on lab automation.

5. Logos Biosystems (Aligned Genetics): Specializes in imaging solutions, which complement Reshape Biotech's automation but focus more on imaging rather than the automation of experiments.

6. Singer Instruments: Focuses on laboratory automation robotics specifically for genetic research, indicating a similar market focus but with different applications.

7. EMS: A long-established supplier of medical equipment, which may benefit from brand recognition and customer trust, providing a competitive edge in the market.

Notable differences among these competitors include their specific focus areas, such as Nagi Bioscience's emphasis on reducing animal testing, Ogi Bio's microbial automation, and Biodock's AI-driven analysis, which may provide them with advantages in their respective niches.

Reshape Biotech primarily focuses on the biotechnology industry, specifically in automating laboratory experiments and enhancing research and development processes through robotics and machine learning technologies.

• Reshape Biotech raised $20 million in a Series A funding round.
• The investors involved in this funding round have not been explicitly named in the available sources.